Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLC

Ahsan Farooqi, Ethan B. Ludmir, Kyle G. Mitchell, Mara B. Antonoff, Chad Tang, Percy Lee, Joe Chang, Yasir Elamin, Daniel R. Gomez, Saumil J. Gandhi

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLC'. Together they form a unique fingerprint.

Medicine & Life Sciences